TOWNSEND RICHARD NOLAN (Chief Executive Officer) sold 0.5% of their position (1.13K shares) of LEXEO THERAPEUTICS, INC. on the open market
Open‑market sale worth $10.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/20/2025ACC: 0001995218-25-000007
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-1.13K
Net shares
Net seller
$10.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.13K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.13K
Price / share
$9.27
Trade value
$10.45K
% of position
0.5%
11/18/2025
242.12K→240.99K
Total
Net shares
−1.13K
Net value
-$10.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/18/2025 | S · Sale | −1.13K | $9.27 | $10.45K | 0.5% | 242.12K | 240.99K |
| Total | −1.13K | -$10.45K | ||||||
Derivative Transactions0
No derivative transactions reported